Procter & Gamble's recent announcement of worldwide price increases for up to 70% of its portfolio in response to commodity cost increases likely foreshadowed commentary other US consumer health product manufacturers will offer with their quarterly results.
Similar comments likely are coming in major firms’ October-December results in the consumer health sector starting with Johnson &...








